Mountains of Gratitude: Supporting Macular Degeneration Research for Future Generations
Meet Fred Jacobson, a dedicated support of Macular Degeneration Research.
Meet Fred Jacobson, a dedicated support of Macular Degeneration Research.
When Fred Jacobson was diagnosed with age-related macular degeneration (AMD) in his mid 70s, he was still leading tours as a professional mountain guide despite having faced retinal tears and bilateral knee replacements. While those medical challenges hadn’t rattled him much, AMD was different—Fred’s mother had developed the disease around the same age. As he and his sister witnessed their mother slowly lose her sight, dementia also stole her memory, so that every day she learned anew that she could no longer see. “It was shattering,” Fred recalled. “Through my mother’s experience, I was set up to be terrified by the whole idea of macular degeneration.”
Thanks to early detection during follow-up for his retinal repairs, and the use of anti-VEGF therapies, Fred’s worst fears didn’t materialize. He continued working until age 80, and today, at 88, continues to juggle multiple volunteer roles. “I’ve been treated for about 10 years with virtually no loss of vision,” he said. “I was, and continue to be, so grateful.”
When Fred learned about BrightFocus Foundation’s Macular Degeneration Research program, he was driven to pay that gratitude with ongoing support. “My philosophy is to be grateful for what’s good in your life and do what you can to make sure the next generation will have those advantages or more,” he said. “The contributions of people like me 20 years ago led to what helped me so much, and is still helping me.”
BrightFocus Foundation’s public information programs and resources also offer tremendous benefit, Fred said. “Not everybody has good doctors or even knows they should get regular eye exams. But BrightFocus makes information on how you can help protect your vision and eye health easily accessible to anyone. That’s a pretty good thing to support.”
“BrightFocus is doing great work,” Fred added. “I appreciate being informed of what’s going on, and I believe in what they’re doing. They’ve helped make huge breakthroughs already, and it seems they’re close to making even more.”
This story originally appeared in BrightFocus Foundation’s 2026 annual report.
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $330 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
Help Fight Macular Degeneration and Save Sight
Your donation helps fund critical research to bring us closer to a cure for this sight-stealing disease and provide vital information to the public.
Donate Today